Authors
1 Department of Clinical Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran
2 Student Research Committee, International Branch, Shiraz University of Medical Sciences, Shiraz, Iran
Abstract
Objective: In this study, we aimed to evaluate the attachment to stress ulcer prophylaxis
(SUP) guideline in the neurology wards of two teaching and nonteaching hospitals.
Methods: A total of 243 patients were retrospectively reviewed in the neurology wards
of two teaching and nonteaching hospitals. To assess the appropriate administration of
SUP, an internal guideline was prepared using the American Society of Health‑System
Pharmacists (ASHP) protocol.
Findings: SUP prescriptions were noncompliant with ASHP guideline in about 93.1%
and 84.6% of cases in the nonteaching and teaching hospitals, respectively.
Conclusion: SUP may be better practiced in teaching hospitals versus nonteaching ones.
Keywords
understanding of pathogenesis and prophylaxis. Drug Intell
Clin Pharm 1988;22:452‑60.
2. Navab F, Steingrub J. Stress ulcer: Is routine prophylaxis
necessary? Am J Gastroenterol 1995;90:708‑12.
3. ASHP Therapeutic guidelines on stress ulcer prophylaxis.
ASHP commission on therapeutics and approved by the
ASHP board of directors on november 14, 1998. Am J Health
Syst Pharm 1999;56:347‑79.
4. Qadeer MA, Richter JE, Brotman DJ. Hospital‑acquired
gastrointestinal bleeding outside the critical care unit: risk
factors, role of acid suppression, and endoscopy findings.
J Hosp Med 2006;1:13‑20.
5. Heidelbaugh JJ, Inadomi JM. Magnitude and economic impact
of inappropriate use of stress ulcer prophylaxis in non‑ICU
hospitalized patients. Am J Gastroenterol 2006;101:2200‑5.
6. Berardi RR, Fugit RV. Peptic ulcer disease. In: DiPiro JT,
Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, editors.
Pharmacotherapy: A Pathophysiologic Approach. 8th ed.
New York: McGraw Hill; 2011. p. 563‑86.
7. Issa IA, Soubra O, Nakkash H, Soubra L. Variables associated
with stress ulcer prophylaxis misuse: A retrospective analysis.
Dig Dis Sci 2012;57:2633‑41.
8. Khalili H, Dashti‑Khavidaki S, Hossein Talasaz AH,
Tabeefar H, Hendoiee N. Descriptive analysis of a clinical
pharmacy intervention to improve the appropriate use of
stress ulcer prophylaxis in a hospital infectious disease ward.
J Manag Care Pharm 2010;16:114‑21.
9. ZeitounA, Zeineddine M, Dimassi H. Stress ulcer prophylaxis
guidelines: Are they being implemented in Lebanese
health care centers? World J Gastrointest Pharmacol Ther
2011;2:27‑35.
10. EidSM, BoueizA, Paranji S, Mativo C, LandisR, AbougergiMS.
Patterns and predictors of proton pump inhibitor overuse
among academic and non‑academic hospitalists. Intern Med
2010;49:2561‑8.
11. Olsen KM, Devlin JW. Comparison of the enteral and
intravenous lansoprazole pharmacodynamic responses in
critically ill patients. Aliment Pharmacol Ther 2008;28:326‑33.
12. Wohlt PD, Hansen LA, Fish JT. Inappropriate continuation
of stress ulcer prophylactic therapy after discharge. Ann
Pharmacother 2007;41:1611‑6
)